Hey Broadway… Never an imposition… the on-going TNBC and Soft Tissue Sarcoma will provide an answer to your question… the primary data collection for the TNBC trial is to be completed this month… but we may not hear anything until??? …ASCO? The STS trial will be completed in January of next year.
I am cautiously optimistic… I do believe that Entremed is on the right track… they have gone from a shotgun approach to narrowing down on the science of cause and effect. If the trials successfully identify a biomarker to select patients who are responsive to Enmd 2076…one does not need to be a genius to understand the value… However, I think it is important to understand that the patient populations are low in these trials, and if there is a significant response, it will most likely have to be validated in larger patient populations…
I am impressed with the current trends and responses occurring in gene therapy… it is almost a “boutique” treatment… specific to the individual with hope for a cure rather than just disease management… it will be interesting to see where this leads…